医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集

in the U.S

Dr. Reddy’s Laboratories Announces the Launch of Deferasirox Film-Coated Tablets, in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Deferasirox Film-Coated Tablets, in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: in the U.S Reddy's Laboratories Announces the Launch

2019年12月06日

Dr. Reddy’s Announces the Launch of Over-the-Counter, Store-Brand Equivalent of Prevacid® 24HR Capsules (Lansoprazole Delayed-Release Capsules USP, 15 mg) in the U.S. Market

バイオテクノロジーヘルスケア臨床試験製薬　 TimeLine: in the U.S Lansoprazole Delayed-Release Capsules USP Reddy's Announces the Launch of Over-the-Counter Store-Brand Equivalent of Prevacid

2019年09月16日

Dr. Reddy’s Laboratories announces the launch of Bupropion Hydrochloride Extended-Release Tablets, USP (SR) in the U.S. Market

Dr. Reddy’s Laboratories announces the launch of Bupropion Hydrochloride Extended-Release Tablets, USP (SR) in the U.S. Market

ヘルスケアヘルス一般製薬　 TimeLine: in the U.S Reddy's Laboratories Announces the Launch

2019年09月05日

Dr. Reddy’s Laboratories Announces the Launch of Ramelteon Tablets, in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Ramelteon Tablets, in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: in the U.S Reddy's Laboratories Announces the Launch

2019年07月23日

Dr. Reddy’s announces the launch of over-the-counter, store-brand equivalent of Allegra-D® 12 HR Allergy and Congestion Extended-Release Tablets (fexofenadine HCl 60 mg and pseudoephedrine HCl 120 mg) in the U.S. Market

バイオテクノロジーヘルスケア製薬　 TimeLine: 12 HR Allergy and Congestion Extended-Release fexofenadine HCl 60 mg and pseudoephedrine HCl in the U.S Reddy's Announces the Launch of Over-the-Counter store-brand equivalent of Allegra-D

2019年07月19日

Sun Pharma Launches Ezallor Sprinkle (Rosuvastatin) in the U.S. for People Who Have Difficulty Swallowing

Sun Pharma Launches Ezallor Sprinkle (Rosuvastatin) in the U.S. for People Who Have Difficulty Swallowing

ヘルスケアマネージド・ケア心臓学製薬　 TimeLine: for People Who Have Difficulty Swallowing in the U.S Sun Pharma Launches Ezallor Sprinkle

2019年07月15日

Dr. Reddy’s Laboratories Announces the Launch of Testosterone Gel, 1.62% (20.25 mg/1.25 g Pump Actuation) in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Testosterone Gel, 1.62% (20.25 mg/1.25 g Pump Actuation) in the U.S. Market

ヘルスケアヘルス一般製薬　 TimeLine: 1.25 g Pump Actuation in the U.S Reddy's Laboratories Announces the Launch

2019年05月06日

Notification of a New Drug Application for HP-3070 (Transdermal Patch for the Treatment of Schizophrenia) in the U.S.

Notification of a New Drug Application for HP-3070 (Transdermal Patch for the Treatment of Schizophrenia) in the U.S.

ヘルスケア製薬　 TimeLine: for the Treatment of Schizophrenia in the U.S Notification of a New Drug Application for Transdermal Patch

2018年12月17日

Notification of the Results of the Phase III Clinical Study of HP-3070 (Transdermal Patch for the Treatment of Schizophrenia) in the U.S.

Notification of the Results of the Phase III Clinical Study of HP-3070 (Transdermal Patch for the Treatment of Schizophrenia) in the U.S.

ヘルスケア臨床試験製薬　 TimeLine: in the U.S Notification of the Results of the Phase Transdermal Patch for the Treatment

2018年01月31日

Dr. Reddy’s Laboratories Announces the Launch of Bupropion HCl Extended-Release Tablets, USP (SR) in the U.S. Market

Dr. Reddy’s Laboratories Announces the Launch of Bupropion HCl Extended-Release Tablets, USP (SR) in the U.S. Market

ヘルスケア心臓学糖尿病腫瘍学製薬　 TimeLine: Extended-Release Tablets in the U.S Reddy's Laboratories Announces the Launch

2016年09月03日